- By insider
President and CEO of Illumina Inc (30-Year Financial, Insider Trades) Francis A Desouza (insider trades) sold 3,000 shares of ILMN on 09/01/2020 at an average price of $352.32 a share. The total sale was $1.1 million.
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products. Illumina Inc has a market cap of $53.22 billion; its shares were traded at around $364.53 with a P/E ratio of 77.86 and P/S ratio of 16.12. Illumina Inc had annual average EBITDA growth of 23.20% over the past ten years. GuruFocus rated Illumina Inc the business predictability rank of 5-star.
CEO Recent Trades:
-
President and CEO Francis A Desouza sold 3,000 shares of ILMN stock on 09/01/2020 at the average price of $352.32. The price of the stock has increased by 3.47% since.
Directors and Officers Recent Trades:
-
SVP Chief Commercial Officer Oene Mark Van sold 625 shares of ILMN stock on 09/01/2020 at the average price of $355.13. The price of the stock has increased by 2.65% since.
-
SVP & General Counsel Charles Dadswell sold 1,687 shares of ILMN stock on 09/01/2020 at the average price of $355.35. The price of the stock has increased by 2.58% since.
-
Director Jay T Flatley sold 4,000 shares of ILMN stock on 09/01/2020 at the average price of $355.35. The price of the stock has increased by 2.58% since.
-
SVP, Global Quality & Ops Robert P Ragusa sold 5,000 shares of ILMN stock on 08/31/2020 at the average price of $355.18. The price of the stock has increased by 2.63% since.
-
Director Jay T Flatley sold 4,000 shares of ILMN stock on 08/18/2020 at the average price of $354.03. The price of the stock has increased by 2.97% since.
For the complete insider trading history of ILMN, click here
.This article first appeared on GuruFocus.